Home › Cancro del polmone non a piccole cellule › California › Roseville
Studi clinici su Cancro del polmone non a piccole cellule a Roseville, CA
10 studi su Cancro del polmone non a piccole cellule cercano partecipanti presso sedi a Roseville e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
In reclutamentoFase 3
- Kaiser Permanente-Roseville, Roseville
- Sutter Roseville Medical Center, Roseville
- Sutter Auburn Faith Hospital, Auburn · a 15 mi di distanza
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
In reclutamentoFase 3
- Kaiser Permanente-Roseville, Roseville
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
In reclutamentoFase 3
- Roseville Medical Plaza Care Center, Roseville
- Sutter Medical Center, Sacramento Infusion Center at Roseville, Roseville
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
In reclutamentoFase 3
- Sutter Health, Roseville
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
In reclutamentoFase 3
- Sutter Institute for Medical Research, Roseville
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
In reclutamentoFase 2
- Kaiser Permanente-Roseville, Roseville
- Sutter Roseville Medical Center, Roseville
- Sutter Auburn Faith Hospital, Auburn · a 15 mi di distanza
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
In reclutamentoFase 2
- Sutter Roseville Medical Center, Roseville
- Sutter Auburn Faith Hospital, Auburn · a 15 mi di distanza
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
In reclutamentoFase 2/3
- Kaiser Permanente-Roseville, Roseville
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
In reclutamentoFase 2
- Sutter Roseville Medical Center, Roseville
- Sutter Auburn Faith Hospital, Auburn · a 15 mi di distanza
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
In reclutamentoStudio osservazionale
- Kaiser Permanente-Roseville, Roseville
- Mercy Cancer Center - Rocklin, Rocklin · a 4 mi di distanza
Studi su Cancro del polmone non a piccole cellule in altre città
- Houston, TX145 studi
- New York City, NY121 studi
- Arlington, VA104 studi
- Nashville, TN97 studi
- Boston, MA90 studi
- Los Angeles, CA87 studi
- St. Louis, MO73 studi
- Chicago, IL61 studi
- Baltimore, MD60 studi
- San Antonio, TX59 studi
- Columbus, OH57 studi
- Washington, DC55 studi
Altri studi a Roseville
- Cancro ai polmoni9 studi
- Cancro alla prostata8 studi
- Cancro al seno7 studi
- Cancro colorettale6 studi
- Diabete di tipo 25 studi
- Leucemia mieloide acuta5 studi
- Cancro del colon5 studi
- Cancro (tutti i tipi)4 studi
- Cancro al rene (carcinoma a cellule renali)4 studi
- Mieloma multiplo3 studi
- Cancro ovarico3 studi
- Cancro del retto3 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.